Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Heron Therapeutics (HRTX) over the last 14 years, with Q3 2025 value amounting to $5.2 million.

  • Heron Therapeutics' Other Working Capital Changes rose 3680.92% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 105949.82%. This contributed to the annual value of $9.9 million for FY2024, which is 16435.24% up from last year.
  • Latest data reveals that Heron Therapeutics reported Other Working Capital Changes of $5.2 million as of Q3 2025, which was up 3680.92% from -$9.3 million recorded in Q2 2025.
  • Heron Therapeutics' 5-year Other Working Capital Changes high stood at $8.6 million for Q1 2025, and its period low was -$9.5 million during Q2 2023.
  • Moreover, its 5-year median value for Other Working Capital Changes was $222000.0 (2024), whereas its average is $338263.2.
  • Over the last 5 years, Heron Therapeutics' Other Working Capital Changes had its largest YoY gain of 377567.57% in 2025, and its largest YoY loss of 311868.51% in 2025.
  • Quarter analysis of 5 years shows Heron Therapeutics' Other Working Capital Changes stood at $2.7 million in 2021, then soared by 75.19% to $4.7 million in 2022, then crashed by 203.58% to -$4.9 million in 2023, then surged by 226.06% to $6.2 million in 2024, then decreased by 14.78% to $5.2 million in 2025.
  • Its Other Working Capital Changes was $5.2 million in Q3 2025, compared to -$9.3 million in Q2 2025 and $8.6 million in Q1 2025.